Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.

Schug C, Gupta A, Urnauer S, Steiger K, Cheung PF, Neander C, Savvatakis K, Schmohl KA, Trajkovic-Arsic M, Schwenk N, Schwaiger M, Nelson PJ, Siveke JT, Spitzweg C.

Mol Cancer Res. 2019 Jan;17(1):310-320. doi: 10.1158/1541-7786.MCR-18-0185. Epub 2018 Sep 17.

PMID:
30224540
2.

Gold-nanostar-based SERS substrates for studying protein aggregation processes.

Schwenk N, Mizaikoff B, Cárdenas S, López-Lorente ÁI.

Analyst. 2018 Oct 22;143(21):5103-5111. doi: 10.1039/c8an00804c.

PMID:
30178815
3.

TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.

Schug C, Urnauer S, Jaeckel C, Schmohl KA, Tutter M, Steiger K, Schwenk N, Schwaiger M, Wagner E, Nelson PJ, Spitzweg C.

Endocr Relat Cancer. 2019 Jan 1;26(1):89-101. doi: 10.1530/ERC-18-0173.

PMID:
30121623
4.

External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.

Schug C, Sievert W, Urnauer S, Müller AM, Schmohl KA, Wechselberger A, Schwenk N, Lauber K, Schwaiger M, Multhoff G, Wagner E, Nelson PJ, Spitzweg C.

Hum Gene Ther. 2018 Nov;29(11):1287-1300. doi: 10.1089/hum.2018.025. Epub 2018 May 3.

PMID:
29724129
5.

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.

Urnauer S, Müller AM, Schug C, Schmohl KA, Tutter M, Schwenk N, Rödl W, Morys S, Ingrisch M, Bertram J, Bartenstein P, Clevert DA, Wagner E, Spitzweg C.

Oncotarget. 2017 Sep 16;8(54):92195-92208. doi: 10.18632/oncotarget.21028. eCollection 2017 Nov 3.

6.

Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.

Schmohl KA, Dolp P, Schug C, Knoop K, Klutz K, Schwenk N, Bartenstein P, Nelson PJ, Ogris M, Wagner E, Spitzweg C.

Thyroid. 2017 Dec;27(12):1534-1543. doi: 10.1089/thy.2017.0290. Epub 2017 Nov 10.

PMID:
29032724
7.

Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.

Urnauer S, Klutz K, Grünwald GK, Morys S, Schwenk N, Zach C, Gildehaus FJ, Rödl W, Ogris M, Wagner E, Spitzweg C.

J Gene Med. 2017 May;19(5). doi: 10.1002/jgm.2957.

PMID:
28423213
8.

Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.

Urnauer S, Morys S, Krhac Levacic A, Müller AM, Schug C, Schmohl KA, Schwenk N, Zach C, Carlsen J, Bartenstein P, Wagner E, Spitzweg C.

Mol Ther. 2016 Aug;24(8):1395-404. doi: 10.1038/mt.2016.95. Epub 2016 May 9.

9.

Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.

Schmohl KA, Müller AM, Schwenk N, Knoop K, Rijntjes E, Köhrle J, Heuer H, Bartenstein P, Göke B, Nelson PJ, Spitzweg C.

Eur Thyroid J. 2015 Sep;4(Suppl 1):74-80. doi: 10.1159/000381019. Epub 2015 May 23.

10.

Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.

Schmohl KA, Müller AM, Wechselberger A, Rühland S, Salb N, Schwenk N, Heuer H, Carlsen J, Göke B, Nelson PJ, Spitzweg C.

Endocr Relat Cancer. 2015 Dec;22(6):941-52. doi: 10.1530/ERC-15-0245. Epub 2015 Aug 25.

PMID:
26307023
11.

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.

Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.

J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662. Epub 2015 Mar 5.

12.

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

Mol Ther Nucleic Acids. 2013 Nov 5;2:e131. doi: 10.1038/mtna.2013.58.

13.

Comparison of the quality of patient referrals from physicians, physician assistants, and nurse practitioners.

Lohr RH, West CP, Beliveau M, Daniels PR, Nyman MA, Mundell WC, Schwenk NM, Mandrekar JN, Naessens JM, Beckman TJ.

Mayo Clin Proc. 2013 Nov;88(11):1266-71. doi: 10.1016/j.mayocp.2013.08.013. Epub 2013 Oct 9.

PMID:
24119364
14.

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

J Nucl Med. 2013 Aug;54(8):1450-7. doi: 10.2967/jnumed.112.115493. Epub 2013 Jul 10.

15.

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.

Knoop K, Schwenk N, Dolp P, Willhauck MJ, Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ, Spitzweg C.

Hum Gene Ther. 2013 Mar;24(3):306-16. doi: 10.1089/hum.2012.104.

16.

Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.

Grünwald GK, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Göke B, Holm PS, Spitzweg C.

Gene Ther. 2013 Jun;20(6):625-33. doi: 10.1038/gt.2012.79. Epub 2012 Oct 4.

PMID:
23038026
17.

6 techniques for creative problem solving.

Varkey P, Hernandez JS, Schwenk N.

Physician Exec. 2009 May-Jun;35(3):50-3. No abstract available.

PMID:
19534316
18.

The transition from an analog to a digital echocardiography laboratory: the Mayo experience.

Hansen WH, Gilman G, Finnesgard SJ, Wellik TJ, Nelson TA, Johnson MF, Schwenk NM, Seward JB, Khandheria BK.

J Am Soc Echocardiogr. 2004 Nov;17(11):1214-24. Review.

PMID:
15502803
19.

Death from inappropriate therapy for Lyme disease.

Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM.

Clin Infect Dis. 2000 Oct;31(4):1107-9.

PMID:
11049799
20.

Increasing the proportion of women in academic medicine: one institution's response.

Heid IM, O'Fallon JR, Schwenk NM, Gabriel SE.

Mayo Clin Proc. 1999 Feb;74(2):113-9.

PMID:
10069346
21.

Management of urinary retention: rapid versus gradual decompression and risk of complications.

Nyman MA, Schwenk NM, Silverstein MD.

Mayo Clin Proc. 1997 Oct;72(10):951-6. Review.

PMID:
9379700
22.

Laryngeal carcinoma presenting as platypnea.

Schwenk NR, Schapira RM, Byrd JC.

Chest. 1994 Nov;106(5):1609-11. Review.

PMID:
7956433
23.

A coproporphyria-like syndrome induced by glipizide.

Moder KG, Schwenk NM.

Mayo Clin Proc. 1991 Mar;66(3):312-6.

PMID:
2002689
24.

Incidence of malignant bone and joint tumors in Olmsted County, Minnesota, 1935 through 1981.

Beard CM, Griffin MR, Schwenk NM, Offord KP, Reiman HM.

Mayo Clin Proc. 1988 Apr;63(4):332-6.

PMID:
3352315
25.

Fatal hemopericardium due to ruptured solitary myocardial abscess unassociated with infective endocarditis.

Winek RR, Schwenk NM, Edwards WD.

Am J Cardiovasc Pathol. 1988;2(3):255-7.

PMID:
3219208
26.

Severe generalized reactions to ibuprofen: report of a case.

Butterfield JH, Schwenk NM, Colville DS, Kuipers BJ.

J Rheumatol. 1986 Jun;13(3):649-50.

PMID:
3735289
27.

Respiratory failure in a 32-year-old farmer due to nitrous dioxide exposure.

Schwenk N.

Minn Med. 1984 Dec;67(12):693. No abstract available.

PMID:
6513915

Supplemental Content

Loading ...
Support Center